American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

RenovoRx, Inc. (RNXT)

$1.29 +1.57% NASDAQ: RNXT · 15-min delayed

MOUNTAIN VIEW, California
Public · NASDAQ: RNXT
17 employees

Visit website Follow

$39.0MMarket cap

$1.1MRevenue · FY2025

-$11.2MNet income

17Employees

RNXTNASDAQ

2021IPO

About RenovoRx, Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: RNXT
Employees: 17
IPO date: Aug 26, 2021
Headquarters: 2570 W. EL CAMINO REAL, STE. 320,
MOUNTAIN VIEW, California 94040
Phone: 408-800-2649
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: RNXT Nasdaq
SEC CIK: 1574094
EIN: 271448452
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show RenovoRx, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/renovorx-inc/"><img src="https://americancompanies.com/badge/renovorx-inc.svg" alt="RenovoRx, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow RenovoRx, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $1.1M
Net income: -$11.2M
Total assets: $8.1M
Market cap: $39.0M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: RNXT

$1.29 +1.57%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.73 $2.52

52-week range

Market cap: $39.0M
Shares outstanding: 30.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Aug 26, 2021

RenovoRx, Inc. (RNXT) Stock Price

Reported a net loss of $11.2M in FY2025.
Trading 49% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review RenovoRx, Inc..

Write a review

Newsroom

News about RenovoRx, Inc.

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer GlobeNewswire Inc. · 2026-08-25 · positive RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 GlobeNewswire Inc. · 2026-04-01 · positive University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial GlobeNewswire Inc. · 2024-06-26 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships GlobeNewswire Inc. · 2024-06-10 Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Benzinga · 2024-01-02 Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Benzinga · 2023-12-28

News & sentiment via Polygon.io

FAQ

RenovoRx, Inc.: frequently asked questions

Is RenovoRx, Inc. an American company?

RenovoRx, Inc. is a US-based company headquartered in Mountain View, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is RenovoRx, Inc. headquartered?

RenovoRx, Inc. is headquartered in Mountain View, California, United States.

Is RenovoRx, Inc. publicly traded?

Yes — RenovoRx, Inc. is a publicly traded company. Its stock trades under the ticker symbol RNXT on the NASDAQ.

What does RenovoRx, Inc. do?

RenovoRx, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore